Trial Information
Inclusion Criteria:
- Colorectal cancer participants were identified by colonoscopy to have at least one
historically confirmed colorectal cancer.
Exclusion Criteria:
- Age<18 years
- Pregnant women
- Had a history of colorectal cancer
- Attenuated adenomatous polyposis coli
- Inflammatory bowel disease or were taking any medication which could influence
homocysteine, folate, vitamin B6 and B12 status, such as H2 blockers, Proton pump
inhibitors, metformin, phenytoin, methotrexates.
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Factorial Assignment, Masking: Double Blind (Subject, Caregiver), Primary Purpose: Prevention
Outcome Measure:
Antioxidant and DNA methylation
Outcome Description:
This study are going to measure the oxidative stress (TBARs), antioxidant activities and DNA methylation in colorectal cancer patients
Outcome Time Frame:
12 months
Safety Issue:
No
Authority:
Taiwan: Department of Health
Study ID:
S10251
NCT ID:
NCT01426490
Start Date:
August 2011
Completion Date:
July 2015
Related Keywords:
- Colorectal Cancer
- Colorectal Neoplasms